A newly filed disclosure shows Hon. Julia Letlow, a member of the U.S. House of Representatives, purchased shares of Centene Corporation common stock (ticker: CNC) in a transaction dated April 14, 2025. The trade was made by Letlow herself, rather than a spouse or dependent, and is held through Merrill Lynch Investment Account #025.
According to the Periodic Transaction Report filed under the STOCK Act, the purchase falls within the $1,001 to $15,000 disclosure bracket, the lowest reporting tier available to members of Congress. The STOCK Act requires lawmakers to report such transactions in broad dollar ranges rather than exact amounts, so the precise size of the position is not publicly known.
A Late Filing
Under the STOCK Act, members of Congress are required to disclose covered transactions within 45 days of becoming aware of them. In this case, the report was filed 119 days after the April 14 transaction date, well past that statutory window. The filing itself does not include an explanation for the delay, and none is offered here. The disclosure has now been made public and is available through the House of Representatives’ financial disclosure system.
Centene Corporation is a managed care organization that operates government-sponsored healthcare programs, including Medicaid and Medicare-related plans, across the United States. Purchases of health insurers by lawmakers occasionally draw attention given congressional committees’ oversight roles in healthcare policy, though the disclosure alone does not indicate any policy connection or intent.
Whoisbuyingnow.com classifies this transaction as a ‘congress buy’ signal, part of its ongoing effort to track equity purchases and sales disclosed by sitting members of Congress. These classifications are based solely on the direction of the reported transaction (buy or sell) and are not a recommendation or endorsement of any investment decision. Readers interested in how professional asset managers position around similar sectors may find our related coverage on 13F filings useful, including our tracker on Fore Capital, LLC’s quarterly portfolio moves.
As with all Periodic Transaction Reports, this filing reflects a legally mandated disclosure rather than any indication of wrongdoing. Members of Congress are permitted to buy and sell individual stocks, subject to the reporting requirements outlined in the STOCK Act. Whoisbuyingnow.com will continue to monitor future filings from Rep. Letlow and other members for additional disclosed activity in Centene Corporation or related healthcare-sector holdings.